[Feature Stock] Remedy, strong on the first day of KOSDAQ listing... Up 30% from IPO price
Remedy is showing strength on its first day of KOSDAQ listing, rising significantly above its IPO price. It is currently trading 30.92% higher than its IPO price.
Key takeaway
"[Feature Stock] Remedy, strong on the first day of KOSDAQ listing... Up 30% from IPO price" — BullBear's AI rates this story as a mixed, direction-neutral signal, with a market-impact score of 40 out of 100. Remedy is showing strength on its first day of KOSDAQ listing, rising significantly above its IPO price. It is currently trading 30.92% higher than its IPO price. Reported by TokenPost on July 13, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Get the next high-impact catalyst
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 49.5%.